Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · IEX Real-Time Price · USD
2.920
+0.100 (3.55%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Oramed Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2006
Net Income
5.53-36.56-22.24-11.51-14.36-12.73-10.48-10.96-7.23-5.7
Upgrade
Depreciation & Amortization
0.20.060.080.010.010.010.01000.01
Upgrade
Share-Based Compensation
4.2111.512.70.470.811.551.580.631.351.47
Upgrade
Other Operating Activities
-20.23-2.92-1.72-1.40.6-3.483.0714.980.940.15
Upgrade
Operating Cash Flow
-10.3-27.92-21.18-12.44-12.94-14.66-5.834.66-4.95-4.07
Upgrade
Capital Expenditures
-0.25-0.47-0.38-0.08-0.02-0.01-0.01-0.01-0-0.01
Upgrade
Change in Investments
-72.7830.68-23.394.7111.28-74.31-16-3.31-13.07
Upgrade
Other Investing Activities
-0-0-0-0-0-0-0-0-
Upgrade
Investing Cash Flow
-73.0430.21-23.764.6311.26-74.3-16.01-3.31-13.09
Upgrade
Share Issuance / Repurchase
2.4311.56101.3923.79022.651.5912.049.7216.64
Upgrade
Debt Issued / Paid
49.55000000000
Upgrade
Other Financing Activities
--0.781.5-------
Upgrade
Financing Cash Flow
51.9810.78102.8923.79022.651.5912.049.7216.64
Upgrade
Exchange Rate Effect
-0.05-0.060-0.010.010.030.010.01-0.010.01
Upgrade
Net Cash Flow
-31.4113.0157.9515.97-1.671.030.060.691.45-0.51
Upgrade
Free Cash Flow
-10.55-28.39-21.56-12.52-12.96-14.66-5.844.65-4.95-4.08
Upgrade
Free Cash Flow Margin
-787.24%-1050.31%-797.48%-462.07%-479.28%-598.69%-237.70%724.80%--
Upgrade
Free Cash Flow Per Share
-0.26-0.73-0.76-0.61-0.74-0.98-0.440.37-0.46-0.44
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).